Searched for
API DEPENDENCE IN PHARMACEUTICALS
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- AI-linked hiring in CDMO industry jumps nearly 3-fold in 2 years: ReportArtificial intelligence skill demand in India's Contract Development and Manufacturing Organisation sector is set to surge. Demand for AI s...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- Preparing for Rupee at 100: What does it mean for the economy and your stock market investments?The Indian rupee is nearing the Rs 100 per dollar mark, driven by rising crude oil prices and foreign investor outflows. This depreciation ...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- China supplies over 30% of India's industrial goods; overdependence on single nation critical: GTRIIndia faces significant reliance on China for industrial goods. China supplies over 30 percent of India's industrial imports. This dependen...
- India following diversified strategy to boost exports to China, cut import dependence: OfficialIndia is pursuing a multi-pronged approach to boost its exports to China. The nation is focusing on building its own industrial capabilitie...
- Govt's ammonia rule to hurt pharma cos as directive restricts sale of surplus to fertiliser firmsIndia’s pharmaceutical industry faces a potential raw material crunch after the government restricted surplus ammonia supply to fertiliser ...
- Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...
- Iran war impact: Essential drugs may cost up to 5% more, for nowThe immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in ...
- Iran conflict: Pharma supply chains may take months to recoverExperts said supply chains disrupted by the conflict will take months to stabilise, and prices of active pharmaceutical ingredients (APIs)-...
- Comm secy asks pharma sector to cut dependence on imported raw materialsIndia's Commerce Secretary Rajesh Agrawal has called for greater self-reliance in the pharmaceutical sector. He wants the industry to produ...
- Local manufacturing of 35 APIs started after PLI scheme: Mandaviya"The 35 APIs are being manufactured from 32 different manufacturing plants. This will give a boost to AatmaNirbhar Bharat," Mandaviya, the ...
- Government likely to widen scope of API scheme to allow exportsIndia’s pharmaceuticals industry is the third largest in the world, but is dependent on China for crucial raw material. The new scheme seek...
- Centre looking to hike import duty on bulk drugs, in bid to boost local manufacturingThe department of pharmaceuticals (DoP) is mulling the proposal as it pushes to make India self-reliant on APIs. A committee of experts for...
Load More
